Letter Sequence Other |
---|
EPID:L-2019-NEW-0004, Shine Medical Technologies, LLC Application for an Operating License (Approved, Closed) |
Initiation
- Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request
- Acceptance, Acceptance
- Supplement, Supplement, Supplement, Supplement, Supplement, Supplement, Supplement, Supplement, Supplement, Supplement, Supplement, Supplement
Results
Other: ML19235A308, ML19324F963, ML20057F950, ML20114E315, ML20126G523, ML20226A262, ML21029A103, ML21053A261, ML21089A228, ML21089A334, ML21096A250, ML21130A314, ML21145A060, ML21161A115, ML21209A997, ML21210A438, ML22042A018, ML22075A331, ML22075A336, ML22095A067, ML22124A073, ML22125A040, ML22152A108, ML22187A134, ML22206A208, ML22216A112, ML22220A261, ML22308A233, ML22322A212, ML22322A223, ML22347A177, ML22347A214, ML22348A067, ML22348A070, ML22348A072, ML23006A185
|
MONTHYEARML19211C0442019-07-17017 July 2019 Shine Medical Technologies, LLC Application for an Operating License Project stage: Request ML19211C1432019-07-17017 July 2019 Shine Medical Technologies, LLC Application for an Operating License Project stage: Request ML19235A3082019-09-0505 September 2019 Shine Medical Technologies, LLC - Cover Letter for Notice of Receipt and Availability of Operating License Application Project stage: Other ML19276D4112019-10-0808 October 2019 Shine Medical Technologies, LLC - Acceptance for Docketing Letter Project stage: Acceptance Review ML19276D4092019-10-0808 October 2019 Shine Medical Technologies, LLC - Operating License Application Acceptance Review Results Project stage: Request ML19276D4102019-10-0808 October 2019 Shine Medical Technologies, LLC - Acceptance for Docketing Federal Register Notice Project stage: Acceptance Review ML19337A2752019-11-14014 November 2019 Shine Medical Technologies, LLC Supplement 1 to Final Safety Analysis Report Project stage: Request ML19353C6872019-12-19019 December 2019 Environmental Site Audit Regarding Shine Medical Technologies, LLC - Proposed Medical Isotope Production Facility Project stage: Request ML19324F9622020-01-0202 January 2020, 6 January 2020 Shine Medical Technologies, LLC - Notice of Opportunity for Hearing and Petition for Leave to Intervene Project stage: Request ML19324F9632020-01-0202 January 2020 Shine Medical Technologies, LLC - Cover Letter for Notice of Opportunity for Hearing and Petition for Leave to Intervene Project stage: Other ML20057F9502020-03-0606 March 2020 Shine Medical Technologies, LLC - Instrumentation and Control Regulatory Audit Plan Project stage: Other ML20105A2952020-03-27027 March 2020 Shine Medical Technologies, LLC, Supplement 2 to License Application, Rev.2 to Final Safety Analysis Report Project stage: Supplement ML20114E3152020-04-30030 April 2020 Shine Medical Technologies, LLC - Operating License Application Technical Review Schedule Project stage: Other ML20126G5232020-05-0707 May 2020 Shine Medical Technologies, LLC - Regulatory Audit Plan Related to Electrical Power Systems Project stage: Other ML20226A2622020-08-14014 August 2020 Shine Medical Technologies, LLC - Accident Analysis and Criticality Safety Audit Plan Project stage: Other ML20255A0272020-08-28028 August 2020 Shine Medical Technologies, LLC Operating License Application Response to Request for Additional Information and Supplement No. 3 Project stage: Supplement ML21309A0192020-10-16016 October 2020 Shine Medical Technologies, LLC - Request for Additional Information Related to Chapters 2, 3, and 8 Project stage: RAI ML20311A1242020-10-30030 October 2020 Shine Medical Technologies, LLC, Operating License Application Supplement No. 4 Submittal of a Revision to the Shine Physical Security Plan Project stage: Supplement ML21309A0232020-11-10010 November 2020 Shine Medical Technologies, LLC - Request for Additional Information Related to Chapters 6 and 13 Project stage: RAI ML20325A0262020-11-13013 November 2020 Submittal of a Mark-Up to the Draft NRG-Proposed SHINE-Specific Security Measures Project stage: Request ML20357A0862020-12-10010 December 2020 Enclosure 1 - Final Safety Analysis Report Change Summary Project stage: Request ML21011A2242020-12-15015 December 2020 Shine Medical Technologies, LLC - Operating License Application Supplement No. 6 and Response to Request for Additional Information Project stage: Supplement ML20352A2252020-12-18018 December 2020 Shine Environmental RAIs - Cumulative Impacts Project stage: RAI ML21309A0442021-01-27027 January 2021 Shine Medical Technologies, LLC - Request for Additional Information Related to Chapters 9 and 11 Project stage: RAI ML21019A1592021-01-27027 January 2021 Public Meeting Summary January 12 2021 Project stage: Meeting ML21029A1032021-01-29029 January 2021 Enclosure 1 - Response to Final Safety Analysis Report Chapters 2, 3, and 8 Requests for Additional Information Project stage: Other ML21029A1022021-01-29029 January 2021 Shine Medical Technologies, LLC Operating License Application Response to Request for Additional Information Project stage: Response to RAI ML21029A0382021-01-29029 January 2021 Request for Exemption from Criticality Accident Alarm System Monitoring Requirements for the Shine Irradiation Unit Cells and Material Staging Building Project stage: Request ML21057A0052021-02-26026 February 2021 Shine Medical Technologies. LLC Application for an Operating License Commitment Change Related to the Submission of a Revision to the Technical Specifications Project stage: Request ML21053A2612021-03-11011 March 2021 Shine Medical Technologies - Geotechnical Audit Plan Project stage: Other ML21075A0122021-03-16016 March 2021 Shine Medical Technologies, LLC - Application for an Operating License, Revision 1 of Shine Response to Request for Additional Information 2.4-1 Project stage: Response to RAI ML21095A2142021-03-23023 March 2021 Shine Medical Technologies, LLC, Revisions to Final Safety Analysis Report, Chapter 6, Engineered Safety Features Project stage: Request ML21095A2222021-03-23023 March 2021 Shine Medical Technologies, LLC, Revisions to Final Safety Analysis Report, Chapter 5, Cooling Systems Project stage: Request ML21095A2292021-03-23023 March 2021 Shine Medical Technologies, LLC, Response to Request for Additional Information and Supplement No. 7 Project stage: Supplement ML21095A2352021-03-23023 March 2021 Shine Medical Technologies, LLC, Cover Letter for Response to Request Tor Additional Information and Supplement No. 7 Project stage: Supplement ML21089A3342021-04-0707 April 2021 Shine Medical Technologies, LLC - Summary of Audit Related to Geotechnical Topics Project stage: Other ML21089A0012021-04-0808 April 2021 Shine Medical Technologies, LLC - Request for Additional Information Related to Meteorological Data, Cooling Systems, and Physical Security Project stage: RAI ML21096A2502021-04-0808 April 2021 Shine Medical Technologies - Fire Protection Audit Plan Project stage: Other ML21106A1362021-04-16016 April 2021 Shine Medical Technologies, LLC Application for an Operating License Revision 1 of Shine Response to Request for Additional Information 3.4-6 Project stage: Response to RAI ML21089A2282021-04-21021 April 2021 Shine Medical Technologies, LLC - Physical Security Plan Audit Summary Project stage: Other ML21130A3132021-05-12012 May 2021 Shine Medical Technologies, LLC - Instrumentation and Control Systems Audit Topics Enclosure 2 Project stage: Request ML21130A3142021-05-12012 May 2021 Shine Medical Technologies, LLC - Instrumentation and Control Systems Audit Plan Project stage: Other ML21145A0602021-06-0202 June 2021 Shine Medical Technologies - Ch 6 8 13 and Exemption RAI Project stage: Other ML21161A1162021-06-10010 June 2021 Shine Medical Technologies, LLC - Cyber Security Audit Plan W/ 2 Encl Project stage: Request ML21161A1152021-06-10010 June 2021 Shine Medical Tech Ltr - Cyber Security Audit Plan Enclosure 1 Project stage: Other ML21162A3182021-07-0101 July 2021 Shine Medical Technologies, LLC - Request for Additional Information Related to Fire Protection Project stage: RAI ML21172A1952021-07-0101 July 2021 Shine Medical Technologies, LLC - Request for Additional Information Related to Instrumentation and Control Systems Project stage: RAI ML21208A1352021-07-27027 July 2021 Shine Medical Technologies, LLC Application for an Operating License Response to Request for Additional Information Project stage: Response to RAI ML21209A9972021-08-0303 August 2021 Shine Medical Technologies, LLC - Update to Operating License Application Technical Review Schedule Project stage: Other ML21210A4382021-08-13013 August 2021 Shine Medical Technologies, LLC - Cyber Security RAI Project stage: Other 2020-08-14
[Table View] |
|
---|
Category:Letter
MONTHYEARML23229A0202023-08-17017 August 2023 Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 ML23087A2272023-05-0505 May 2023 Shine Technologies, LLC - Issuance of Amendment No. 4 to Construction Permit No. CPMIF-001 for the Receipt and Possession of Contained Special Nuclear Material ML23086C0502023-04-27027 April 2023 Shine Technologies, LLC - Letter, Environmental Assessment and Finding of No Significant Impact ML23088A3382023-04-0505 April 2023 Shine Technologies, LLC - Review of the Physical Security Plan in Support of an Operating License for a Medical Radioisotope Production Facility ML23010A1982023-02-24024 February 2023 Shine Technologies, LLC - Letter: Safety Evaluation Report for the Shine Medical Radioisotope Production Facility Operating License Application ML23048A2442023-02-17017 February 2023 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 Response to Request for Additional Information ML23034A1872023-02-0303 February 2023 Shine Medical Technologies, LLC Notice of Availability of Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility (Docket Number: 50-608) ML23010A2382023-02-0303 February 2023 Shine Technologies, LLC - Individual Notice of Consideration FRN Letter ML23023A0942023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23023A0922023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23023A0862023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23024A1682023-02-0101 February 2023 Letter to Ken Westlake, EPA Region 5 - Issuance of Final EIS Supplement Related to the Operating License ML23024A1742023-02-0101 February 2023 Dr. Gregory Piefer, Chief Executive Officer - Issuance of Final EIS Supplement Related to the Operating License ML22287A1852023-02-0101 February 2023 Shine Technologies, LLC Regulatory Report on the Audit of Phased Startup Operations Application Supplement ML22308A2332023-01-0909 January 2023 Shine Technologies LLC - Regulatory Audit Report for Chapter 8 - Irradiation Facility and Radioisotope Production Facility Electrical Power Systems ML22347A2142023-01-0404 January 2023 Shine Technologies LLC - Regulatory Audit Report for I&C Combined Sessions ML22356A1932022-12-22022 December 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Confirmatory Information ML22347A1772022-12-14014 December 2022 Shine Technologies LLC - Regulatory Audit Report for Programmable Logic Lifecycle ML22301A1492022-12-0707 December 2022 Shine Technologies, LLC - Regulatory Audit Report for Chapter 13 - Accident Analysis and Criticality Safety ML22322A2122022-12-0202 December 2022 Shine Medical Technologies - Cybersecurity Audit Summary Report ML22322A2232022-12-0202 December 2022 Shine Medical Technologies - Fire Protection Audit Summary Report ML22348A0672022-12-0101 December 2022 Shine Technologies, LLC - Request for Confirmatory Information Related to Instrumentation and Control Systems ML22335A5722022-12-0101 December 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22292A3192022-11-30030 November 2022 Shine Medical Technologies, LLC Issuance of Order and Amendment No. 3 to Construction Permit No. CPMIF-001 ML22318A1782022-11-14014 November 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22304A1262022-10-31031 October 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22279A9512022-10-0606 October 2022 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 ML22271A9632022-09-28028 September 2022 Shine Technologies, LLC Application for an Operating License Supplement No. 31 Revision to the Phased Startup Operations Application Supplement ML22263A3442022-09-20020 September 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Additional Information ML22263A0272022-09-19019 September 2022 Shine Technologies, LLC - Application for an Operating License - Response to Request for Confirmatory Information ML22220A2612022-09-12012 September 2022 Shine Technologies LLC - Regulatory Report on the Audit Chapter 14, Technical Specifications ML22251A3272022-09-0808 September 2022 Shine Technologies, LLC Application for an Operating License Revision 1 of Shine Response to Requests for Additional Information 7-38, 7-40, and 7-48 ML22249A1252022-08-31031 August 2022 Shine Technologies, LLC Final Safety Analysis Report - Application for an Operating License Supplement No. 30, Cover Letter ML22105A1102022-08-26026 August 2022 Shine Medical Technologies LLC - Request for Additional Information Related to the OGC Review of Phrase Approach ML22061A2122022-08-24024 August 2022 Shine Medical Technologies LLC - Regulatory Audit Plan for Phased Approach - Session 1 ML22213A0492022-08-0101 August 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22187A1342022-08-0101 August 2022 Shine Technologies, LLC - Update to Operating License Application Technical Review Schedule ML22206A2082022-07-27027 July 2022 Shine Medical Technologies, LLC - Request for Confirmatory Information Related to Radiation Protection Program and Waste Management ML22207A0062022-07-26026 July 2022 Shine Technologies, LLC Application for an Operating License Supplement No. 29 ML22202A4492022-07-21021 July 2022 Shine Technologies, LLC Operating License Application Supplement No. 28 - Submittal of a Revision to the Shine Emergency Plan ML22188A2412022-07-14014 July 2022 Meeting with Shine Medical Technologies, LLC (EPID No. L-2019-NEW-0004), to Discuss Development of Shine'S Cybersecurity Program for It'S Medical Isotope Production Facility ML22175A0392022-07-11011 July 2022 Letter to Reid Nelson, Achp Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22175A0542022-07-0808 July 2022 Letter to Gregory Piefer - Notice of Availability of the Draft EIS Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML22175A0912022-07-0808 July 2022 Notice of Availability and Request for Comments on the Draft Environmental Impact Statement Supplement Related to the Operating License for the Shine (Multiple Tribal Letters) ML22175A0772022-07-0808 July 2022 Letter to Daina Penkiunas - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22175A0632022-07-0808 July 2022 Letter to Ken Westlake, EPA Region 5 - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22188A1942022-07-0707 July 2022 Shine Technologies, LLC, Application for an Operating License Supplement No. 27 ML22188A0562022-07-0707 July 2022 Shine Technologies, LLC Operating License Application Supplement No. 26 Submittal of a Revision to the Shine Material Control and Accounting Plan ML22223A0662022-07-0606 July 2022 Shine Technologies, LLC, Application for an Operating License, Revision 1 of the Response to Requests for Additional Information Related to Cyber Security ML22175A0742022-07-0101 July 2022 Letter to Mary Buelow Maintenance of Reference Materials at the Hedberg Public Library for the Environmental Review of Shine Medical Technologies, LLC Operating License Application 2023-08-17
[Table view] Category:Report
MONTHYEARML23229A0202023-08-17017 August 2023 Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 ML22271A9642022-09-28028 September 2022 Enclosure 1: Phased Startup Operations Application Supplement Change Summary ML22271A9662022-09-28028 September 2022 Enclosure 3: Phase Startup Operations Application Supplement (Public Version) ML22049A0242022-02-18018 February 2022 Shine Technologies, LLC, Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 ML22027A3562022-01-27027 January 2022 Shine Technologies, LLC, Application for an Operating License Supplement No. 15 Submittal of the Phased Startup Operations Application Supplement ML21130A3132021-05-12012 May 2021 Shine Medical Technologies, LLC - Instrumentation and Control Systems Audit Topics Enclosure 2 ML21089A3342021-04-0707 April 2021 Shine Medical Technologies, LLC - Summary of Audit Related to Geotechnical Topics ML21053A2602021-03-11011 March 2021 Shine Medical Technologies - Geotechnical Audit Topics ML20052C7942020-02-21021 February 2020 Shine Medical Technologies, Inc., Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 ML19234A0472019-08-22022 August 2019 Shine Medical Technologies - Periodic Report Required by the License Conditions in Section 3.0.(1) of CPMIF-001 ML19233A1752019-08-21021 August 2019 Fws Information for Planning and Conservation (Ipac) Trust Resources Report for Shine Production Facility Operating License ML19233A1552019-08-21021 August 2019 Wisconsin Depart of Natural Resources Endangered Resources Preliminary Assessment for Shine Operating License ML16041A4712016-02-26026 February 2016 SHINE Medical Technologies, Inc. - Construction Permit for Medical Isotope Facility ML16041A4702016-02-26026 February 2016 SHINE Medical Technologies, Inc. - Summary Record of Decision ML15043A4082015-01-26026 January 2015 Enclosure 2, Attachment 1 - REPORT-TEC-01-15, Revision 1, Estimation of Uncertainty in Radiolysis Gas Production in the TSV (Public) ML14357A3542014-12-0303 December 2014 Attachment 11 - NSA-TR-SHN-13-05, Revision 1, Shine Physics Validation ML14357A3602014-12-0303 December 2014 Attachment 5 - ANL-CSE-14-11, Shine Target-Solution Chemistry: Thermodynamic Modeling of Speciation, Precipitate Formation, and the Chemical Effects of Stainless Steel Corrosion ML14357A3612014-12-0303 December 2014 Attachment 6 - ANL-CSE-13-38, FY13 Progress Report on the Phase I Mini-Shine Water Irradiations and Micro-Shine Irradiations ML14357A3632014-11-30030 November 2014 Attachment 8 - LA-UR-14-28684, Stability of Fissile Solution Systems ML14357A3622014-10-31031 October 2014 Attachment 7 - 1200-09-02 Rev. 0, Shine Target Solution Qualification Program ML14296A1962014-09-19019 September 2014 Enclosure 2, Attachment 3: Report-TEC-01-15, Revision 0, Estimation of Uncertainty in Radiolysis Gas Production in the Tsv. 2023-08-17
[Table view] Category:Miscellaneous
MONTHYEARML22049A0242022-02-18018 February 2022 Shine Technologies, LLC, Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 ML21130A3132021-05-12012 May 2021 Shine Medical Technologies, LLC - Instrumentation and Control Systems Audit Topics Enclosure 2 ML21089A3342021-04-0707 April 2021 Shine Medical Technologies, LLC - Summary of Audit Related to Geotechnical Topics ML21053A2602021-03-11011 March 2021 Shine Medical Technologies - Geotechnical Audit Topics ML20052C7942020-02-21021 February 2020 Shine Medical Technologies, Inc., Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 ML19234A0472019-08-22022 August 2019 Shine Medical Technologies - Periodic Report Required by the License Conditions in Section 3.0.(1) of CPMIF-001 ML19233A1752019-08-21021 August 2019 Fws Information for Planning and Conservation (Ipac) Trust Resources Report for Shine Production Facility Operating License ML19233A1552019-08-21021 August 2019 Wisconsin Depart of Natural Resources Endangered Resources Preliminary Assessment for Shine Operating License ML16041A4712016-02-26026 February 2016 SHINE Medical Technologies, Inc. - Construction Permit for Medical Isotope Facility ML16041A4702016-02-26026 February 2016 SHINE Medical Technologies, Inc. - Summary Record of Decision ML14357A3612014-12-0303 December 2014 Attachment 6 - ANL-CSE-13-38, FY13 Progress Report on the Phase I Mini-Shine Water Irradiations and Micro-Shine Irradiations ML14357A3602014-12-0303 December 2014 Attachment 5 - ANL-CSE-14-11, Shine Target-Solution Chemistry: Thermodynamic Modeling of Speciation, Precipitate Formation, and the Chemical Effects of Stainless Steel Corrosion ML14357A3542014-12-0303 December 2014 Attachment 11 - NSA-TR-SHN-13-05, Revision 1, Shine Physics Validation ML14357A3632014-11-30030 November 2014 Attachment 8 - LA-UR-14-28684, Stability of Fissile Solution Systems ML14357A3622014-10-31031 October 2014 Attachment 7 - 1200-09-02 Rev. 0, Shine Target Solution Qualification Program 2022-02-18
[Table view] |
Text
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 April 7, 2021 Dr. Gregory Piefer, Chief Executive Officer SHINE Medical Technologies, LLC 101 East Milwaukee Street, Suite 600 Janesville, WI 53545
SUBJECT:
SHINE MEDICAL TECHNOLOGIES, LLC -
SUMMARY
OF AUDIT RELATED TO GEOTECHNICAL TOPICS (EPID NO. L-2019-NEW-0004)
Dear Dr. Piefer:
By letter dated July 17, 2019 (Agencywide Documents Access and Management System (ADAMS) Accession No. ML19211C044), as supplemented by letters dated November 14, 2019 (ADAMS Accession No. ML19337A275), March 27, 2020 (ADAMS Accession No. ML20105A295), August 28, 2020 (ADAMS Accession No. ML20255A027),
November 13, 2020 (ADAMS Accession No. ML20325A026), December 10, 2020 (ADAMS Accession No. ML20357A084), and December 15, 2020 (ADAMS Accession No. ML21011A264), SHINE Medical Technologies, LLC (SHINE) submitted to the U.S. Nuclear Regulatory Commission (NRC) an operating license application for its proposed SHINE Medical Isotope Production Facility in accordance with the requirements contained in Title 10 of the Code of Federal Regulations Part 50, Domestic Licensing of Production and Utilization Facilities.
To enhance the review of geotechnical topics associated with the SHINE operating license application the NRC staff conducted a regulatory audit on March 16, 2021. A summary of the regulatory audit is enclosed.
G. Piefer If SHINE has any questions please contact me at 301-415-1524, or by electronic mail at Steven.Lynch@nrc.gov.
Sincerely, Steven T. Lynch Steven T. Lynch, Senior Project Manager Non-Power Production and Utilization Facility Licensing Branch Division of Advanced Reactors and Non-Power Production and Utilization Facilities Office of Nuclear Reactor Regulation Docket No. 50-608 Construction Permit No. CPMIF-001
Enclosure:
As stated cc: See next page
SHINE Medical Technologies, LLC Docket No. 50-608 cc:
Jeff Bartelme Licensing Manager SHINE Medical Technologies, LLC 101 East Milwaukee Street, Suite 600 Janesville, WI 53545 Nathan Schleifer General Counsel SHINE Medical Technologies, LLC 101 East Milwaukee Street, Suite 600 Janesville, WI 53545 Christopher Landers Director, Office of Conversion National Nuclear Security Administration, NA 23 U.S. Department of Energy 1000 Independence Avenue, SW Washington, DC 20585 Mark Paulson Supervisor Radiation Protection Section Wisconsin Department of Health Services P.O. Box 2659 Madison, WI 53701-2659 Test, Research and Training Reactor Newsletter Attention: Amber Johnson Dept. of Materials Science and Engineering University of Maryland 4418 Stadium Drive College Park, MD 20742-2115 Mark Freitag City Manager P.O. Box 5005 Janesville, WI 53547-5005 Bill McCoy 1326 Putnam Avenue Janesville, WI 53546 Alfred Lembrich 541 Miller Avenue Janesville, WI 53548
ML21089A334 NRR-106 OFFICE NRR/DANU/PM NRR/DANU/LA NRR/DEX/BC NRR/DANU/BC (A) NRR/DANU/PM NAME SLynch NParker JColaccino DHardesty SLynch DATE 4/2/2021 4/5/2021 4/5/2021 4/7/2021 4/7/2021 OFFICE OF NUCLEAR REACTOR REGULATION REGULATORY AUDIT
SUMMARY
REGARDING GEOTECHNICAL TOPICS DESCRIBED IN OPERATING LICENSE APPLICATION SHINE MEDICAL TECHNOLOGIES, LLC CONSTRUCTION PERMIT NO. CPMIF-001 SHINE MEDICAL ISOTOPE PRODUCTION FACILITY DOCKET NO. 50-608 Location: SHINE Medical Technologies, LLC, Janesville, Wisconsin Audit Date: March 16, 2021 Audit Team Members: Steven Lynch, Senior Project Manager Zuhan Xi, Geotechnical Engineer Amitava Ghosh, Geotechnical Engineer Joseph Colaccino, Chief, Structural, Civil, and Geotechnical Engineering Branch Licensee Representatives: Jeff Bartelme, SHINE Director of Licensing Jim Costedio, SHINE Vice President of Regulatory Affairs and Quality Abbey Donahue, SHINE Structural Engineering Manager Marc Anderson, Sargent & Lundy Joshua Bickett, Sargent & Lundy Jonathan Dean, Sargent & Lundy David Nielson, Sargent & Lundy
1.0 BACKGROUND
By letter dated July 17, 2019 (Agencywide Documents Access and Management System (ADAMS) Accession No. ML19211C044), as supplemented by letters dated November 14, 2019 (ADAMS Accession No. ML19337A275), March 27, 2020 (ADAMS Accession No. ML20105A295), August 28, 2020 (ADAMS Accession No. ML20255A027),
November 13, 2020 (ADAMS Accession No. ML20325A026), December 10, 2020 Enclosure
(ADAMS Accession No. ML20357A084), and December 15, 2020 (ADAMS Accession No. ML21011A264), SHINE Medical Technologies, LLC (SHINE) submitted to the U.S. Nuclear Regulatory Commission (NRC) an operating license application for its proposed SHINE Medical Isotope Production Facility in accordance with the requirements contained in Title 10 of the Code of Federal Regulations (10 CFR) Part 50, Domestic Licensing of Production and Utilization Facilities. This regulatory audit was intended to assist the NRC staff in its review of the geotechnical topics described in the SHINE final safety analysis report (FSAR), submitted as part of SHINEs operating license application.
This audit supported the NRC staffs review of the licensees geotechnical topics program using the applicable 10 CFR requirements, as well as the guidance contained in NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors, Format and Content, issued February 1996 (ADAMS Accession No. ML042430055),
and NUREG-1537, Part 2, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors, Standard Review Plan and Acceptance Criteria, issued February 1996 (ADAMS Accession No. ML042430048). The NRC staff is also using the Final Interim Staff Guidance [ISG] Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, dated October 17, 2012 (ADAMS Accession No. ML12156A069), and Final Interim Staff Guidance Augmenting NUREG-1537, Part 2, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Standard Review Plan and Acceptance Criteria, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, dated October 17, 2012 (ADAMS Accession No. ML12156A075). As applicable, additional guidance cited in SHINEs FSAR or referenced in NUREG-1537, Parts 1 and 2, or the ISG Augmenting NUREG-1537, Parts 1 and 2, has been utilized in the review of the SHINE operating license application.
The audit was conducted in accordance with the audit plan and associated topics (ADAMS Package No. ML21053A259).
2.0 AUDIT ACTIVITIES AND OBSERVATIONS Entrance Briefing The NRC staff discussed the goals and objectives of the audit at the entrance briefing, which focused on gaining a better understanding of SHINE geotechnical topics. In addition, it was discussed that the regulatory audit may identify additional information that would be required to be docketed to support the basis of the licensing decision and allow NRC staff to more efficiently gain insights on the operating license application. Further, the NRC staff indicated that the information gained from the audit review would assist the NRC staff to better focus any requests for additional information (RAIs) needed to support the review.
Review of Audit Information SHINE made the documents listed in Table 1, Audit Review Documents, available on its electronic reading room for NRC staff to review in preparation for the regulatory audit discussions. The documents included the evaluation of ultimate bearing capacity and allowable soil bearing capacity, as well as a calculation package for the structural design of the SHINE facility, including a detailed total settlement analysis and the predicted subgrade modulus of the site soils for the structural analysis.
Table 1, Audit Review Documents Document No. Title Revision Date Golder Report #8 of Geotechnical Calculations, Bearing 1 08/03/2012 Project No. 113-81051 Capacity, and Settlement Sargent & Lundy Report SHINE Facility Structural Design 8 01/27/2021 CALC-2017-1000 Summary of Observations The NRC staff reviewed the documents listed in Table 1 to verify information provided in SHINEs response to RAI 3.4-6, provided by letter dated December 15, 2020 (ADAMS Accession No. ML21011A264). Specifically, the NRC staff sought to confirm that the allowable soil bearing pressure is higher than the foundation contact pressures and that differential and total settlements are not beyond maximum allowable values. The NRC staff focused its audit review on the Golder Report #8, as well as Attachment P, Evaluation of Soil Subgrade Modulus, and Attachment X, DL and LL Diagram for Geotechnical Calculations, of Sargent &
Lundy Report CALC-2017-1000.
The NRC staff examined the analyses and calculations in the reference documents and confirmed that that the soil properties used for the analysis are proper and conservative. For SHINEs bearing capacity evaluation, the NRC staff noted that the calculation method is widely accepted and used by the industry. The NRC staff acknowledged that the assumption of a small foundation size in the calculation leads to a conservative estimate of the bearing capacity.
For SHINEs settlement calculation, the NRC staff noted that the total settlement was evaluated by three different recognized methods.
The NRC staff conducted a regulatory audit teleconference on March 16, 2021, with SHINE to better understand how the analyses and calculations provided in the electronic reading room support the information provided by SHINE in its response to RAI 3.4-6. The following topics were discussed during the teleconference:
allowable soil bearing capacities, including the predicted maximum foundation contact pressure from structural response analyses; allowable settlement limits; settlement profile in consideration of loading variation over the mat foundation, rigidity of mat foundation, and subgrade soil material; and soil depth of influence used in settlement analysis.
Based on the review of the information provided to the NRC staff to review via the internet portal and the discussion at the audit teleconference on March 16, 2021, the NRC staff found that SHINE provided an evaluation of ultimate and allowable bearing capacities that is conservative and acceptable to support information provided in the FSAR and agreed upon revisions to the FSAR and RAI response.
Exit Briefing On March 16, 2021, the NRC staff held an exit meeting with the licensee. No issues or concerns were identified by the licensee during the audit exit briefing. The NRC staff indicated the audit was concluded.
3.0 RESULTS OF REGULATORY AUDIT During the regulatory audit, SHINE provided clarification and/or justification of the information provided in its response to RAI 3.4-6 and additional detail related to the NRC staff discussion topics. As a result of these discussions, SHINE agreed to revise its application materials as follows:
- 1) Clarify the net allowable static bearing pressure in FSAR Section 3.4.2.6.3.1, Soil Parameters, provide information on the predicted maximum foundation contact pressure from the structural response analyses under design loading conditions, and verify the maximum pressure that can be enveloped by the allowable soil bearing capacity.
- 2) Supplement the response to RAI 3.4-6 to include the information that the facility structure is designed to accommodate the potential differential and total settlements of the foundation of the facility structure and, consequently, that there are no allowable settlement limits.
Since SHINE agreed to voluntarily supplement the FSAR and the response to RAI 3.4-6, the NRC staff did not identify any outstanding issues following the conclusion of this regulatory audit.